Innov Clin Neurosci. 2017;14(1–2):11–12. Dear Editor: Sexual dysfunction (SD) after traumatic brain injury (TBI) is an often neglected and underreported issue within the medical field.[1,2] A recent interesting work by
Innov Clin Neuro. 2017;14(1–2):12–13. Dear Editor: Hyperglycemia is more common in patients being treated with an antipsychotic than in the general population.[1] However, hypoglycemia is also a severe complication of
Innov Clin Neurosci. 2016;13(7–8):15–16. Dear Editor: Borderline personality disorder (BPD) is over-represented in prison populations, with 25 to 50 percent of incarcerated individuals suffering from this disorder.[1] As an empirical
Innov Clin Neurosci. 2016;13(7–8):13–14. Dear Editor: Substance use disorders frequently coexist with and complicate the treatment of mood and anxiety disorders. Gabapentin is one of the most commonly prescribed off-label
Innov Clin Neurosci. 2016;13(5–6):13–14 Dear Editor: Brown and Rais[1] offer an interesting case report of the autistic son of a mother with a “multisystem litany of symptoms and diseases… typical
Dear Editor: Polydipsia can lead to episodic life-threatening water intoxication and is a serious problem in many patients with chronic schizophrenia.[1] Although multiple factors have been implicated,[2] the reason why
Dear Editor: Consciousness is a multifaceted concept that has two major components: awareness of environment of self (i.e., the content of consciousness) and wakefulness (i.e., the level of consciousness). Whereas
Dear Editor: The frequent emergence of new illicit drugs and the ever-evolving trends in their use continue to cause difficulties for clinicians in regard to screening, detection, and treatment and
Dear Editor: An estimated 75 million Americans experience nonmalignant chronic pain,[1] and oftentimes the responsibility for management falls to the primary care provider. Therefore, pain management is an increasingly important
Dear Editor: Adherence to recommendations provided by healthcare professionals to patients is of keen importance to salutary outcomes. However, patients may, for a number of reasons, be nonadherent. Given that
Dear Editor: I wish to comment on an article that was published in the November-December 2014 issue of Innovations in Clinical Neuroscience on disclosure of psychological testing information.[1] I find
Dear Editor: Multiple sclerosis (MS) is a relatively frequent inflammatory autoimmune illness of the central nervous system affecting about 2.5 million people around the world and representing the most common
Dear Editor: Atypical long-acting injectable (LAI) antipsychotics may improve treatment options for patients with serious mental illnesses, such as schizophrenia and bipolar disorder.[1] A systematic review of 1,700 outpatients from
Innov Clin Neurosci. 2015;12(3–4):11–13.
Innov Clin Neurosci. 2015;12(3–4):10–11.
Innov Clin Neurosci. 2015;12(1–2):10–11.
R. Jordan Bohinc, DO; Randy A. Sansone, MD; and Stephen McDonald, MD Dr. Bohinc is a resident in the Department of Internal Medicine at Kettering Medical Center in Kettering, Ohio;
by Adrian Meule, Dipl-Psych From the Institute of Psychology, University of Wurzburg, Wurzburg, Germany Innov Clin Neurosci. 2014;11(3–4):10–13
Dear Editor: Antidepressant-induced excessive sweating (ADIES) is a common antidepressant-related side effect, and its prevalence is estimated to range from 4 to 22 percent.[1] Adverse effects are a common reason
Dear Editor: We describe a patient who presented with repeated episodes of hypoglycemia, confirmed by laboratory studies, which unfolded as the surreptitious use of insulin. Upon further evaluation, this patient
